跳至主要内容
临床试验/IRCT2012110411364N1
IRCT2012110411364N1已完成2 期

Evaluation of Intralipid efficacy for decreasing Amphotericin B-related nephrotoxicity in patients with fungal infections admitted in Amir-Alam and Imam Khomeini hospitals in Tehran during 1390-1391

Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • patients with fungal infections admitted in Amir-Alam and Imam Khomeini hospitals in Tehran during 1390-1391 who need Amphotericin B for treatment.
  • Exclusion criteria: pathologic hyperlipidemia; patient receiving other nephrotoxic drugs like aminoglycoside simultaneously; severe liver failure or cirrhosis; ESRD under hemodialysis or peritoneal dialysis; baseline serum creatinine over 2mg/dL; hypersensitivity to fat emulsions,egg and soya; pancreatitis

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran University of Medical Sciences

相似试验